What Sterigenics Is and What It Does
Sterigenics is a global sterilization services company that uses gamma radiation, electron beam, and ethylene oxide to sterilize medical devices, pharmaceuticals, and packaging. Headquartered in the United States, it operates facilities in North America, Europe, and Asia, serving medical device manufacturers and life sciences companies that require validated, low microbial load products. Sterigenics is a key part of the healthcare supply chain because many single-use devices and implantable tools cannot be sterilized by the end user according to industry analysis on medical device sterilization.
The company offers contract sterilization, laboratory testing, and packaging validation services that help manufacturers meet regulatory requirements from the FDA, EMA, and other agencies. Sterigenics follows ISO 11137 for radiation sterilization and ISO 11135 for ethylene oxide processing, and it provides dose audits and bioburden testing to support sterile barrier system integrity. Its services are used by original equipment manufacturers, contract manufacturers, and distributors that need repeatable, large-scale sterilization without building their own irradiation facilities.
Sterigenics Technologies and Service Offerings
Sterigenics primarily uses gamma irradiation from cobalt-60 sources and high-energy electron beams to destroy microorganisms on medical devices and single-use products. Gamma sterilization is suited for sealed final packaging, while e-beam offers faster throughput and lower dose uniformity concerns for certain polymers and components. The company also provides ethylene oxide sterilization for heat-sensitive devices and offers environmental monitoring, biological indicators, and sterility assurance level testing as outlined by the FDA on sterilization methods.
Key Service Categories
Sterigenics offers terminal sterilization for finished devices, component sterilization for contract manufacturers, and laboratory services for dose verification and material compatibility studies. It also provides packaging validation to ensure sterile barriers remain intact after sterilization and distribution. These services support products such as surgical instruments, implantable devices, drug delivery systems, and in-vitro diagnostics.
Ownership, Scale, and Market Position
Sterigenics is owned by STERIS plc, which completed its acquisition of the company and now operates it as part of a broader infection prevention and sterilization platform. STERIS serves hospitals, pharmaceutical companies, and medical device manufacturers, and Sterigenics remains a primary brand for gamma and e-beam irradiation services. The combined entity operates multiple facilities globally and processes millions of units annually, making it one of the largest independent sterilization providers in the world per recent SEC filings on STERIS ownership and operations.
Sterigenics competes with other irradiation and ethylene oxide providers such as Nordion, Isomedix, and regional contract sterilizers. Its market position is supported by validated processes, regulatory approvals, and a global footprint that reduces logistics costs for manufacturers shipping devices to hospitals and distributors. The company continues to expand capacity in response to rising demand for single-use devices and prefilled drug delivery systems.